Tirzepatide
GIP / GLP-1 dual agonist · 10mg
Research summary
Tirzepatide is a dual GIP / GLP-1 receptor agonist peptide used in metabolic and incretin-pathway research.
- Standard-content vial for metabolic research
- Studied in incretin and glucose-handling research models
- Independently assayed for identity and purity
Observed in research
Research suggests Tirzepatide may be associated with appetite-regulation and weight-related metabolic pathways under study.
Statements describe findings reported in published laboratory and pre-clinical research. They are not claims about this product, have not been evaluated by any regulatory authority, and do not imply suitability for human or animal use.
For laboratory research use only. This product is not a drug, supplement, or food and is not intended for human or animal consumption, diagnostic, or therapeutic use.
Pay by Cash on Delivery or cryptocurrency (10% off). Same-day dispatch from Bangkok · discreet, tracked nationwide shipping.
